Awards for March 2013


Federal Awards 

Amatruda, James, Children’s Hosp. Philadephia/NIH, NIH COG Chair Grant, $10,590; Baum, Michel, NIH, Neonatal Proximal Tubular Acidification (MPI), $271,090; Berry, Jarett, NIH, Magnetic Resonance Imaging of Carotid Artery Subclinical Artherosclerosis, $132,517; Bowens, Cindy, Univ. of Pennsylvania/NIH, Sedation Management in Pediatric Patients with Acute Respiratory Failure (RESTORE), $14,496; Burgess, Shawn, Duke Univ./NIH, Development of Novel Therapies for NIDDM: Project 3, $349,342; Byerly, Matthew, Columbia Univ./NIH, 2/2: Comparison of Long-Acting Injectable Medication for Schizophrenia (ACLAIMS), $6,337; Cannon, Stephen, NIH, Molecular Physiology of Myotonia and Periodic Paralysis, $381,864; Casey, Brian, NIH, NICHD Maternal Fetal Medicine Units Network, $281,907; Cavanagh, Dwight, Jaeb Ctr./NIH, Cornea Donor Study, $500; Chen, Benjamin, NIH, DNA-PKcs Phosphorylation on Hematopoietic Stem Cells Genome Maintenance, $148,466.

Chen, David, NIH, Pathway Choice of DNA Double-Strand Break Repair, $148,466; Collins, Robert, Natl. Marrow Donor Program/NIH, Blood and Marrow Transplant Clinical Trials Network, $1,250; Cowell, Lindsay, NIH, RepServer: Antigen Receptor Repertoire Analysis Pipelines Via the WWW, $610,482; Deberardinis, Ralph, Johns Hopkins Univ./U.S. Dept. of Defense, Oxygen-Regulated Metabolic Homeostasis: Therapeutic Implications of Paradigm Shift, $42,242; Drazner, Mark, Duke Univ./NIH, STICH-Surgical Treatment of Ischemic Heart Failure, $150; Freeman, Anne, CPRIT, STD/HIV Prevention Training Centers, $578,582; Freeman, Anne, CPRIT, Capacity-Building Assistance (CBA) to Improve Delivery and Effectiveness of HIV Prevention Services, $259,200; Galindo, Rene, NIH, Clinical and Basic NIDDK Research Training for Medical Students, $80,688; Greilich, Philip, New England Research Inst./NIH, Transfusion Medicine/Hemostasis Clinical Trials Network (TMH), $17,320.

Hamilton, Caroline, NIH, Dopamine's Role in the Rapid Estradiol Enhancement of Excitatory Synapses, $109,034; Holland, William, NIH, Adiponectin Receptors and S1P Signaling in Beta Cell Survival and Proliferation, $87,978; Idris, Ahamed, Univ. of Washington/NIH, ROC Protocols; PROPHET/BLAST/RESCUE Studies, $250,610; Johnson, Jane (T. Vue, Fellow), NIH, Role of Asc11 in Glioma, $52,190; Kehoe, Siobhan, UT M.D. Anderson/NIH, Early Detection of Epithelial Ovarian Cancer, $19,191; Kliewer, Steven, NIH, Regulation of Metabolism by Hormone FGF15/19, $301,212; Kraus, Lee, NIH, Role of PARP-1 in Hormone-Related Transcription, $411,774; Le, Lu, NIH, Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics, $148,466; Leavey, Patrick, Children’s Hosp. Philadelphia/NIH, NIH COG Chair Grant, $30,000; Liu, Yi, NIH, Mechanism and Functions of Small RNA Pathways in Neurospora, $286,200.

Lu, Hanzhang, NIH, Cognition and Cerebrovascular Function Across the Lifespan, $272,213; Lu, Richard, NIH, Chromatin Remodeling Control of CNS Myelination and Remyelination, $313,031; Lu, Richard, NIH, Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets, $313,031; Lum, Lawrence, NIH, Chemical Disruption of Wnt-Mediated Signal Transduction, $348,005; Macdonald, Raymond, NIH, Transcriptional Regulators of Exocrine Pancreatic Development, $301,212; Malloy, Craig, Duke Univ./NIH, Development of Novel Therapies for NIDDM: Project 4, $467,179; Meeks, Julian, NIH, Functional Organization of Neural Circuits in Mouse Accessory Olfactory Bulb, $223,676; Mendelson, Carole, NIH, Cellular Mechanisms in Induction of Aromatase, $360,986; Miller, David, Gynecologic Oncology Group/NIH, Gynecologic Oncology Group Studies (Per Capita), $29,115; Moe, Orson, NIH, Klotho and FGF23 in Chronic Kidney Disease: Pathogenesis and Potential Therapy, $311,243.

Mohan, Chandra, NIH, Lupus Genes and B-Cell Signaling, $302,156; Nedzi, Lucien, American Coll. of Radiology/NIH, Radiation Therapy Oncology Group (RTOG); Agreement No. 5915, $16,250; Nesbitt, Shawna, Minneapolis Med. Research Fndtn./NIH, ASPirin in Reducing Events in Elderly, $11,400; Norgard, Michael, UT Med. Branch/NIH, Outer Membrane Proteins of Francisella Tularensis as Acellular Vaccines, $83,481; Punaro, Marilynn, Montefiore Med. Ctr./NIH, IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis, $1,386; Raskin, Philip, George Washington Univ./NIH, Glycemia Reduction Approaches for Diabetes: Comparative Effectiveness (GRADE) - Part I, $233,451; Rodan, Aylin, NIH, Using Drosophila to Understand WNK and SPAK/OSR1 Regulation of SLC12 Cotransporters, $145,331; Rutherford, Cynthia, UT HSC Houston/CDC, Public Health Surveillance for Prevention of Complications of Bleeding and Clotting Disorders, $17,463.

Sanchez, Pablo, NIH, NICHD Cooperative Multicenter Neonatal Research Network, $281,909; Sanchez, Pablo, Univ. of Alabama/NIH, Natural History of CMV-Related Hearing Loss and Feasibility of CMV Screening; CHIMES, $159,070; Sanchez, Pablo, RTI Intl./NIH, NICHD Neonatal Research Network Capitation Funding, $37,239; Satterthwaite, Anne, NIH, Functional Relationships Between Lupus Susceptibility Loci Lyn and Ets1, $154,017; Schaffer, Joseph, RTI Intl./NIH, NICHD Pelvic Floor Disorders Network - Capitation Funding, $390; Schmid, Sandra, NIH, Defining the Role of Dynamin in Endocytosis, $344,025; Schmid, Sandra, NIH, Defining the Role of Dynamin in Endocytosis, $18,817; Schoggins, John, NIH, Interactions between Type 1 and III Interferon During Resolution of HCV Infection, $147,139; Shay, Jerry, Univ. of Nebraska/NIH, SPORE in Gastrointestinal Cancer, $111,703; Sherry, Dean, NIH, Metabolism in the Heart by NMR, $397,500; Sherry, Dean, Duke Univ./NIH, Development of Novel Therapies for NIDDM: Core A, $158,792.

Skapek, Stephen, Children’s Hosp. Philadephia/NIH, NIH COG Chair Grant, $13,262; Sumpter, Rhea, NIH, Novel Host Factors in Selective Autophagy of Viruses, $130,356; Sweeney, John, Univ. of Georgia/NIH, Neural Mechanisms for Antisaccade Errors Among Schizophrenia Families, $137,605; Toto, Robert, Univ. of Utah/NIH, Systolic Blood Pressure Intervention Trial (SPRINT) - Capitated, $63,639; Trivedi, Madhukar, NIH, Clinical Trial Network: North Texas Node - Protocol Supplement, $1,461,486; Udugamasooriya, Damith, NIH, Phosphatidylserine Targeted Tumor Cell Lytic Peptoids, $231,708; Zinn, Andrew, NIH, SIM1 Function in Feeding Regulation, $301,212.


Non-Federal Awards

Cannon, Carolyn, Univ. of North Carolina/Cystic Fibrosis, Culture-based vs. Observant Therapy (Treat or Observe), $10,000; Courtney, Ardith, Jordan Research and Education Inst./Novartis, Study of Functional Index for Living with Multiple Sclerosis (FILMS) in Community-Based and UNIV-Based MS Practice Settings, $10,200; Gupta, Rana, Searle Scholars Program, Defining Adipocyte Progenitors and their Developmental Origins, $100,000; Hooper, Lora (M. Derebe, Fellow), UNCF/Merck Science Initiative, Retinol Binding Function of Serum Amyloid A Proteins, $70,000; Jain, Raksha, Seattle Children’s Research Inst./Cystic Fibrosis, G551D Observational Study, $2,347; Koh, Andrew, March of Dimes Fndtn., Role of Candida Albicans in Development of Neonatal Bacteremia, $75,000; Lee, Simon, CPRIT, Breast Screening and Patient Navigation 2 (BSPAN2), $984,525; Lu, Richard, Natl. Multiple Sclerosis Society, MicroRNA Control of Myelination and Remyelination in Central Nervous System, $25,831.

Mendelson, Carole, March of Dimes Fndtn., Cellular Mechanisms in Initiation of Labor, $136,916; Morrison, Sean (E. Piskounova, Fellow), Helen Hay Whitney Fndtn., Role of Lyn Kinase on Melanoma Metastasis, $50,500; Nguyen, Benjamin, Medtronic Neuromodulation, Medtronic Spasticity Management Fellowship FY2013, $25,000; Powell, Craig, Autism Speaks, Temporally Controlled Genetic Rescue of Shank3 Autism Model, $60,000; Rohatgi, Anand, Merck & Co. Inc., Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease Biomarker, $53,558; Sadler, John, Timberlawn Fndtn., Feasibility and Pilot Study of the UT Southwestern Virtue Inventory for Clinician Excellence, $14,000; Sadler, John, UT System, Feasibility and Pilot Study of the UT Southwestern Virtue Inventory for Clinician Excellence - UT System Supplement, $3,920; Westover, Kenneth, CPRIT, Recruitment of First-Time, Tenure-Track Faculty Members, $399,740.

Industry Sponsored Awards, dollar amounts not available

Beutler, Bruce, Genetic Studies of IBD and Autoimmunity; Chin, Kelly, Ph2 Study of AIR001 in Subjects with WHO Group 1 Pulmonary Arterial Hypertension; Gerber, David, Ph3 Trial of BMS-936558 vs. Docetaxel in Previously Treated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC); Husain, Mustafa, Controlled Trial of Transcranial Direct Current Stimulation as Treatment for Unipolar and Bipolar Depression; Lemack, Gary, Study of AF-219 in Subjects with Interstitial Cystitis/Bladder Pain Syndrome; Lingvay, Ildiko, Study Comparing EndoBarrier Gastrointestinal Liner System vs. Sham for Glycemic Improvement on Obese Type 2 Diabetic Subjects (ENDO Trial); Luna, Michael, Trial Comparing Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans; Novakovic, Roberta, THERAPY Trial: Assess Penumbra System in Treatment of Acute Stroke; Pawlowski, Karen, Influence of Absorbance Enhancers on Antibiotic Concentrations.

Raskin, Philip, Study of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects with Type 2 Diabetes Mellitus; Schiller, Joan, Ph2 Study of Oral LDK378 in Adult Patients with ALK-Activated Non-Small Cell Lung Cancer Previously Treated with Chemotherapy and Crizotinib; Schiller, Joan, Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in Treatment of Non-Small Cell Lung Cancer (NSCLC); Timaran, Carlos, Zenith TX2 Low-Profile Endovascular Graft for Blunt Thoracic Aortic Injury Clinical Study; Yordy, John, PhI Study of IV CUDC-101 with Concurrent Cisplatin and Radiation Therapy in Subjects with Locally Advanced Head and Neck Cancer; Yordy, John, TRYHARD: Ph2 Study of Lapatinib (Tykerb) for Non-HPV Locally Advanced Head and Neck Cancer with Concurrent Chemoradiation; Zuniga, John, Ph3 Study of CL-108 in Treatment of Moderate to Severe Pain.